SCHEMBL2404029

SCHEMBL2404029

O=C(c1cc[nH]n1)N(c1ccccc1)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.45
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.36
NR3C2 P08235 1/20 0.36
CHRM4 P08173 2/20 0.35
CHRM3 P20309 2/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM5 P08912 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17205113 0.85 PTGIR (0.45) NPSR1TDP1L3MBTL1ALDH1A1KMT2A
SCHEMBL6003817 0.83 KDM4E (0.50) ATMKMT2APOLBNPC1HTT
SCHEMBL19663987 0.81 NCOA1 (0.53) NPSR1ATMALDH1A1POLBMAPT
SCHEMBL4458935 0.76 NPSR1 (0.47) NPSR1ATMTDP1L3MBTL1ALDH1A1
SCHEMBL3424139 0.76 SMN1; SMN2 (0.44) NPSR1ATMTDP1L3MBTL1ALDH1A1
Benzene SCHEMBL15668588 0.74 ALOX15 (0.46) TDP1L3MBTL1ALDH1A1KMT2APOLB
SCHEMBL6905225 0.74 KMT2A (0.46) NPSR1ATMTDP1L3MBTL1ALDH1A1
SCHEMBL398536 0.74 NPSR1 (0.44) NPSR1ATMTDP1L3MBTL1ALDH1A1
SCHEMBL2078311 0.73 SMN1; SMN2 (0.39) ALDH1A1KMT2ARAB9AMAPTMEN1
SCHEMBL7790 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011119345-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-09-29 WO claimed
EP-2550258-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbvie Inc. (US) 2013-01-30 EP disclosed
WO-2011119345-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-09-29 WO disclosed